Product Information
CAPECITABINE 150 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3615 per EA under NDC 00093747306. Its NADAC has been published 201 times since Nov 19, 2014.
Strength
150 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093747306
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CAPECITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA091649On Market Since
3/7/2014
Pharmacological Classes
Price Statistics
The NADAC for CAPECITABINE 150 MG TABLET has been published 201 times since Nov 19, 2014, and over the history we have for it it has declined 95.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3615 per EA |
|---|---|
| All-time high | $8.2671 (Jul 15, 2015) |
| All-time low | $0.2292 (Mar 19, 2025) |
| 52-week high | $0.4038 |
| 52-week low | $0.3615 |
| Median price | $0.4399 |
| Average price | $3.6573 |
| Largest weekly change | -92.6% (May 22, 2024) |
| Weeks tracked | 201 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CAPECITABINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 150 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3615 per EA (NDC 00093747306), effective Jun 24, 2026.
How has the price of CAPECITABINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPECITABINE 150 MG TABLET has declined 95.6%. It has been tracked across 201 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for CAPECITABINE 150 MG TABLET?
Since Nov 19, 2014, the NADAC for CAPECITABINE 150 MG TABLET has ranged from a low of $0.2292 (Mar 19, 2025) to a high of $8.2671 (Jul 15, 2015), with a median of $0.4399 per EA.
Are there cheaper alternatives to CAPECITABINE 150 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as CAPECITABINE 150 MG TABLET, but none are currently priced below it.
Who manufactures CAPECITABINE 150 MG TABLET?
CAPECITABINE 150 MG TABLET (NDC 00093747306) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification